Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) (“Calyx” or the “Company”) is pleased to announce that its wholly owned subsidiary Cannigistics Agri-Solutions Corp. (“Cannigistics”) has launched its first consumer facing Cloud (LEAFHub) which is based on the company’s innovative “FocusPoint” Software Platform.
LEAFHub will be Canada’s first real-time, mass communication consumer cloud that provides the Canadian Medical Marijuana user a safe and secure forum to discuss, compare, evaluate, or otherwise locate and comment on the various products available in the market today. “We are confident that over time, the LEAFHub Cloud will become a very popular destination with both consumers and licensed producers,” states President and CEO, Roger Forde.
The next LEAFHub Cloud to launch will be Washington State, followed by Colorado, and ultimately (depending on the November 8th, 2016 referendum) California.
As each state may potentially have thousands of potential consumers, it necessary they each have their own unique implementation of the LEAFHub Cloud to ensure that any and all specific state laws are recognized and adhered to.
LEAFHub Cloud could easily become a standard method of consumer mass communication and information exchange for both the recreational and medical marijuana industry in these states.
The rollouts of these Clouds are scheduled to begin the 2nd week of November 2016 with an anticipated completion date by the 3rd week of December 2016.
About Calyx
Calyx’s wholly owned subsidiary, Cannigistics Agri-Solutions Corp, is a software development company that has created a software platform that is well-suited to advanced indoor agriculture. The Cannigistics software platform is designed to enhance the efficiency and effectiveness of indoor agricultural operations, and positions Cannigistics to be an industry leader in agri-software solutions by providing businesses with advanced controls over various aspects of their operations. Additionally, Calyx owns a portfolio of proprietary intellectual property with applications in crop enhancement.
For further information, please visit www.calyxbio.com.
ON BEHALF OF THE BOARD OF DIRECTORS,
Roger Forde, Director, President and Chief Executive Officer
Forward-Looking Statements: This document contains certain forward-looking statements concerning Calyx and/or its subsidiaries, as well as other expectations, plans, goals, objectives, information or statements about future events, conditions, or performance that may constitute “forward-looking statements” or “forward-looking information” under applicable securities legislation. Such statements or information involve substantial known and unknown risks and uncertainties, certain of which are beyond Calyx’s control. Such forward-looking statements or information are based on a number of assumptions, which may prove to be incorrect.
Although Calyx believes that the expectations reflected in such forward-looking statements or information are reasonable, undue reliance should not be placed on forward-looking statements because Calyx can give no assurance that such expectations will prove to be correct. Forward-looking statements or information are based on current expectations, estimates and projections that involve a number of risks and uncertainties which could cause actual results to differ materially from those anticipated by Calyx and described in the forward-looking statements or information.
The forward-looking statements or information contained in this news release are made as of the date hereof and Calyx undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise unless so required by applicable securities laws or the TSX Venture Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Calyx Bio-Ventures Inc.
Roger Forde
President & CEO
(604) 880-8822
rogerf@calyxbio.com
www.calyxbio.com

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less